Tumor-stromal IL1β/ NFκB / ESE3 Signal Axis Drives Pancreatic Cancer Fibrosis, Chemoresistance, Prognosis

作者: Tiansuo Zhao , Di Xiao , Fanjie Jin , Hongwei Wang , Jing Liu

DOI: 10.1101/2020.07.27.222455

关键词:

摘要: Pancreatic stellate cells (PSCs) play a pivotal role in pancreatic fibrosis and ductal adenocarcinoma (PDAC) progression. The mechanisms controlling PSC activation is not completely understood. Here we investigated the of ESE3 (Epithelium-Specific ETS factor 3) activation. We discovered that PDAC patients expression was increased while decreased tumor cells. overexpression promoted Condition medium from ESE3-overexprssing promotes cell migration, chemoresistance, growth fibrosis. directly induced transcription -SMA, Collagen 1 IL-1{beta} by binding to sites on their promoters activate PSC. On other hand, upregulates through NF{kappa}B required for derived IL-1{beta}. Clinical data showed upregulation positively correlated with size, pTNM stage, CA19-9, CEA CA242 level serum. an independent negative prognostic disease-free survival overall among patients. Inhibition IL-1{beta}/ (PSC)/ positive feedback loop represents promising therapeutic strategy reduce increase chemotherapeutic efficacy PDAC.

参考文章(35)
Susumu Yamazaki, Nobuhiro Nakano, Asuka Honjo, Mutsuko Hara, Keiko Maeda, Chiharu Nishiyama, Jiro Kitaura, Yoshikazu Ohtsuka, Ko Okumura, Hideoki Ogawa, Toshiaki Shimizu, The Transcription Factor Ehf Is Involved in TGF-β–Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells Journal of Immunology. ,vol. 195, pp. 3427- 3435 ,(2015) , 10.4049/JIMMUNOL.1402856
Silke Appel, Anita Bringmann, Frank Grünebach, Markus M. Weck, Jürgen Bauer, Peter Brossart, Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs. Blood. ,vol. 107, pp. 3265- 3270 ,(2006) , 10.1182/BLOOD-2005-06-2480
M Sinn, C Denkert, J K Striefler, U Pelzer, J M Stieler, M Bahra, P Lohneis, B Dörken, H Oettle, H Riess, B V Sinn, α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study British Journal of Cancer. ,vol. 111, pp. 1917- 1923 ,(2014) , 10.1038/BJC.2014.495
Ralf Jesnowski, Daniel Fürst, Jörg Ringel, Ying Chen, Andrea Schrödel, Jörg Kleeff, Armin Kolb, Wolfgang D Schareck, Matthias Löhr, Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine. Laboratory Investigation. ,vol. 85, pp. 1276- 1291 ,(2005) , 10.1038/LABINVEST.3700329
Eric S Silverman, Rebecca M Baron, Lyle J Palmer, Louis Le, Arlene Hallock, Venkat Subramaniam, Richard J Riese, Matthew D McKenna, Xuesong Gu, Towia A Libermann, Antonio Tugores, Kathleen J Haley, Stephanie Shore, Jeffrey M Drazen, Scott T Weiss, None, Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung American Journal of Respiratory Cell and Molecular Biology. ,vol. 27, pp. 697- 704 ,(2002) , 10.1165/RCMB.2002-0011OC
Koen Kas, Eduardo Finger, Franck Grall, Xuesong Gu, Yasmin Akbarali, Jay Boltax, Avi Weiss, Peter Oettgen, Rosana Kapeller, Towia A. Libermann, ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. Journal of Biological Chemistry. ,vol. 275, pp. 2986- 2998 ,(2000) , 10.1074/JBC.275.4.2986
Victor I Sementchenko, Dennis K Watson, Ets target genes: past, present and future Oncogene. ,vol. 19, pp. 6533- 6548 ,(2000) , 10.1038/SJ.ONC.1204034
Huan Xie, Xiaomei Bian, Amit Anil Deorukhkar, Sunil Krishnan, Abstract 2889: Development of a novel nanoconstruct for tumor hypoxia photothermal therapy Cancer Research. ,vol. 72, pp. 2889- 2889 ,(2012) , 10.1158/1538-7445.AM2012-2889
S Mitsunaga, M Ikeda, S Shimizu, I Ohno, J Furuse, M Inagaki, S Higashi, H Kato, K Terao, A Ochiai, Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. British Journal of Cancer. ,vol. 108, pp. 2063- 2069 ,(2013) , 10.1038/BJC.2013.174